<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>Ozette是一家使用AI增强免疫系统监控以用于癌症治疗决策的初创公司，由Madrona Venture Group领投了600万美元的种子轮 Ozette, a startup using AI to enhance immune system monitoring for use in cancer treatment decisions, raises a $6M seed round led by Madrona Venture Group</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script>
<script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">Ozette, a startup using AI to enhance immune system monitoring for use in cancer treatment decisions, raises a $6M seed round led by Madrona Venture Group<br/>Ozette是一家使用AI增强免疫系统监控以用于癌症治疗决策的初创公司，由Madrona Venture Group领投了600万美元的种子轮 </h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2021-02-17 18:42:41</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2021/2/f54eb0e910a33df0abb1cd90e55b2e1a.jpg"><img src="http://img2.diglog.com/img/2021/2/f54eb0e910a33df0abb1cd90e55b2e1a.jpg" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>Cancer patients receive a check-in to see how their immune cells are working and whether the disease is responding to treatment. This immune monitoring is a routine part of cancer care and it helps guide treatment decisions. Yet current analysis methods remain limited, according to Ali Ansary, co-founder and CEO of startup Ozette.</p><p>癌症患者将接受检查，以查看其免疫细胞如何发挥作用以及该疾病是否对治疗有反应。这种免疫监测是癌症护理的常规部分，有助于指导治疗决策。初创公司Ozette的联合创始人兼首席执行官Ali Ansary表示，目前的分析方法仍然有限。</p><p>   The Seattle-based company aims to take immune monitoring further and it is using artificial intelligence to do it. The approach could accelerate analysis of the immune system, helping clinicians make better diagnostic and treatment decisions. The technology could yield insights not only for cancer care, but also infectious disease, inflammatory disorders, and more, said Ansary, who is an attending physician at the University of Washington Medical Center.</p><p>   这家总部位于西雅图的公司旨在进一步进行免疫监控，并正在使用人工智能来实现。该方法可以加快对免疫系统的分析，帮助临床医生做出更好的诊断和治疗决策。华盛顿大学医学中心的主治医师安萨里说，这项技术不仅可以为癌症护理提供见解，而且还可以为传染病，炎症性疾病等提供见识。</p><p> Ozette is now unveiling its technology along with $6 million in seed funding. The financing was led by Madrona Venture Group, with participation from the Allen Institute for Artificial Intelligence (AI2) and Vulcan Capital. Ozette, incubated within AI2.</p><p> Ozette现在宣布其技术以及600万美元的种子资金。融资由Madrona Venture Group牵头，Allen人工智能研究所（AI2）和Vulcan Capital参与。在AI2中孵育的Ozette。</p><p> Immune monitoring is currently done by taking a blood sample from a patient and looking at single cells to see whether a patient’s immune cells are functioning and how they’re responding to a therapy. Single-cell analysis isn’t new, but it is producing more data and a fraction of it is being used. Ozette ramps up the analysis by applying AI.</p><p> 目前，通过从患者身上采集血液样本并观察单个细胞来观察患者的免疫细胞是否起作用以及它们对疗法的反应情况，从而进行免疫监测。单细胞分析并不是什么新鲜事物，但是它会产生更多的数据，并且只有一部分被使用。 Ozette通过应用AI加强了分析。</p><p> Ozette has developed algorithms to understand cell types, said Greg Finak, Ozette’s co-founder and chief technology officer. The company applies AI to sift through the data to provide a better understanding of what’s happening with cells, measuring things that weren’t previously possible. The technology also accelerates and automates the process. Work that would take months with current techniques can be done in hours, Finak said. Quick insights from single-cell data can then be used to inform patient care.</p><p> Ozette的联合创始人兼首席技术官Greg Finak说，Ozette已开发出可理解细胞类型的算法。该公司使用AI筛选数据，以更好地了解细胞正在发生的事情，并测量以前不可能发生的事情。该技术还可以加速和自动化该过程。 Finak说，使用当前技术需要花费数月的工作可以在数小时内完成。然后，可以使用来自单细胞数据的快速见解来告知患者护理。</p><p> “What our technology allows us to do is to now see the cells of the immune system at several orders of magnitude higher,” Finak said. “We can get a bigger, better picture of what the immune system is doing than was previously possible.”</p><p> Finak说：“我们的技术允许我们做的就是看到免疫系统的细胞高出几个数量级。” “我们可以比以前更全面，更好地了解免疫系统在做什么。”</p><p> The Ozette technology comes from the Fred Hutchinson Cancer Research Institute in Seattle where Finak is a scientist. The company’s founders did occasional consulting work for clients looking to manage their data. Finak said those clients were looking for help extracting information from their data but as a research organization, Fred Hutch is limited in what it can do. Some clients preferred to engage with a company. The growing demand for data insight led the founders to form Ozette.</p><p> Ozette技术来自Finak担任科学家的西雅图弗雷德·哈钦森癌症研究所。该公司的创始人偶尔为希望管理其数据的客户提供咨询服务。 Finak说，这些客户正在寻求帮助，以从他们的数据中提取信息，但是作为研究机构，Fred Hutch的能力有限。一些客户倾向于与公司合作。对数据洞察力的需求不断增长，促使创始人组建了Ozette。 </p><p> Ansary said that Ozette has built its technology with between $6 million and $8 million in grant funding. The seed financing is for building the company. The insights Ozette’s technology uncovers about immune cells could be used to develop new therapies and diagnostics, but Ansary said that’s not where his company is going—at least not at first. He describes Ozette as a technology company in the life sciences. The startup’s first focus is finding immuno-oncology insights that can improve the care of cancer patients. The near-term plan is to continue to develop the technology and establish partnerships with cancer research centers and companies.</p><p>Ansary说，Ozette的技术已经建立在600万至800万美元的赠款资金中。种子资金用于建立公司。 Ozette的技术发现的有关免疫细胞的见解可用于开发新的疗法和诊断方法，但Ansary表示，这并不是他公司的发展方向-至少一开始不是。他将Ozette描述为生命科学领域的技术公司。这家初创公司的首要重点是寻找可以改善癌症患者护理的免疫肿瘤学见解。近期计划是继续开发该技术，并与癌症研究中心和公司建立合作伙伴关系。</p><p> Ozette is one of a growing number of companies using AI to gain insight into the immune system. Adaptive Biotechnologies, a fellow Seattle company with roots at Fred Hutch, is working with Microsoft to  decode the immune system. Their research focuses specifically on the T-cell receptor. Last year, startup  Immunai launched and unveiled its single-cell analysis technology that is the basis for its efforts to build a map of the immune system. The New York-company announced a  $60 million Series A round of funding last week that it will use to discover and develop better, more targeted immunotherapies.</p><p> Ozette是使用AI深入了解免疫系统的越来越多的公司之一。自适应生物技术公司是西雅图的一家公司，其根基是弗雷德·哈奇（Fred Hutch），该公司正在与微软合作解码免疫系统。他们的研究专门针对T细胞受体。去年，初创公司Immunai推出并公开了其单细胞分析技术，这是其努力建立免疫系统图谱的基础。这家位于纽约的公司上周宣布获得6000万美元的A轮融资，它将用于发现和开发更好的，更有针对性的免疫疗法。</p><p> Ozette currently employs eight but Ansary said he expects headcount will double in the next few months, and double again by early next year. True to the interdisciplinary nature of the startup, those hires will come from a wide range of disciplines including data science, computational immunology, and software engineering.</p><p> 奥泽特目前有八名员工，但安萨里表示，他预计未来几个月员工人数将翻一番，到明年年初再翻一番。真正符合创业公司的跨学科性质，这些员工将来自广泛的学科，包括数据科学，计算免疫学和软件工程。</p><p> “What we’re trying to do is build a really strong culture here that’s diverse in perspectives, diverse in backgrounds,” Ansary said. “That’s one of the core values we’re establishing here.”</p><p> Ansary说：“我们正在努力做的是在这里建立一种真正强大的文化，这种文化具有不同的观点，不同的背景。” “这是我们在这里建立的核心价值之一。” </p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://medcitynews.com/2021/02/startup-ozette-unveils-ai-approach-to-understanding-the-immune-system/">https://medcitynews.com/2021/02/startup-ozette-unveils-ai-approach-to-understanding-the-immune-system/</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/ai/">#ai</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/led/">#led</a></button></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/恶搞/">#恶搞</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/qq/">#qq</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/工具/">#工具</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/分享/">#分享</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy; 2020 diglog.com </div></div></body></html>